Norris Medicines Ltd. - Research Center
524414 NORRIS Group (XT) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 21 | Dec' 20 | Sep' 20 | Jun' 20 | Dec' 19 | |
|---|---|---|---|---|---|
| Sales | 2.57 | 4.67 | 3.16 | 1.84 | 1.76 |
| Operating profit | -1.06 | 0.14 | -0.84 | 0.01 | -0.39 |
| Interest | 1.05 | 0.20 | 0.28 | 0.11 | 0.15 |
| Gross profit | -2.08 | -0.06 | -1.11 | -0.07 | -0.54 |
| EPS (Rs) | -3.20 | -0.24 | -1.30 | -0.25 | -0.72 |
Quarterly
results in details
| Mar' 21 | Dec' 20 | Sep' 20 | Jun' 20 | Dec' 19 | |
|---|---|---|---|---|---|
| Other income | 0.02 | - | - | 0.02 | - |
| Stock adjustment | -1.02 | 0.40 | -0.21 | 0.04 | -0.16 |
| Raw material | 3.10 | 2.71 | 2.82 | 0.90 | 0.98 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.83 | 0.98 | 0.81 | 0.49 | 0.88 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.72 | 0.44 | 0.59 | 0.41 | 0.45 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.13 | 0.18 | 0.18 | 0.18 | 0.18 |
| Taxation | 0.97 | - | - | - | - |
| Net profit / loss | -3.17 | -0.24 | -1.29 | -0.25 | -0.72 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 9.93 | 9.93 | 9.93 | 9.93 | 9.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -41.02 | 2.92 | -26.41 | 0.75 | -21.92 |
| GPM (%) | -80.01 | -1.33 | -35.16 | -3.89 | -30.66 |
| NPM (%) | -122.18 | -5.18 | -40.84 | -13.54 | -40.75 |
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis